Your browser doesn't support javascript.
loading
Prolactin, a potential biomarker for chronic GVHD activity.
Salas, Maria Queralt; Ezzat, Shereen; Lam, Wilson; Law, Arjun Datt; Pasic, Ivan; Michelis, Fotios V; Kim, Dennis Dong Hwan; Gerbitz, Armin; Al-Shaibani, Zeyad; Viswabandya, Auro; Kumar, Rajat; Mattsson, Jonas; Lipton, Jeffrey Howard.
Afiliación
  • Salas MQ; Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Ezzat S; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Lam W; Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, Barcelona, Spain.
  • Law AD; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Pasic I; Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Michelis FV; Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Gerbitz A; Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Al-Shaibani Z; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Viswabandya A; Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Kumar R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Mattsson J; Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Eur J Haematol ; 106(2): 158-164, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33047394
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prolactina / Biomarcadores / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prolactina / Biomarcadores / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá